EXOMIND (BTL-995) for Reduction of Binge-eating

Clinical trial NCT06910592 · COMPLETED

Trial details

NCT number: NCT06910592
Sponsor: BTL Industries Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Binge-Eating Disorder

Start date: 2023-07-26
Primary completion: 2023-12-15
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.